Related references
Note: Only part of the references are listed.Virus entry paradigms
Manjula Kalia et al.
AMINO ACIDS (2011)
Adeno-Associated Virus 2 Infection Requires Endocytosis through the CLIC/GEEC Pathway
Mathieu Nonnenmacher et al.
CELL HOST & MICROBE (2011)
Unique Characteristics of AAV1, 2, and 5 Viral Entry, Intracellular Trafficking, and Nuclear Import Define Transduction Efficiency in HeLa Cells
Nicholas W. Keiser et al.
HUMAN GENE THERAPY (2011)
Structural Studies of Adeno-Associated Virus Serotype 8 Capsid Transitions Associated with Endosomal Trafficking
Hyun-Joo Nam et al.
JOURNAL OF VIROLOGY (2011)
Enhancers of Adeno-associated Virus AAV2 Transduction via High Throughput siRNA Screening
Alexis J. Wallen et al.
MOLECULAR THERAPY (2011)
Novel Properties of Tyrosine-mutant AAV2 Vectors in the Mouse Retina
Hilda Petrs-Silva et al.
MOLECULAR THERAPY (2011)
Proteasome inhibitors induce nucleolar aggregation of proteasome target proteins and polyadenylated RNA by altering ubiquitin availability
L. Latonen et al.
ONCOGENE (2011)
Intrinsic phospholipase A2 activity of adeno-associated virus is involved in endosomal escape of incoming particles
Stefanie Stahnke et al.
VIROLOGY (2011)
AAV Exploits Subcellular Stress Associated with Inflammation, Endoplasmic Reticulum Expansion, and Misfolded Proteins in Models of Cystic Fibrosis
Jarrod S. Johnson et al.
PLOS PATHOGENS (2011)
Comparative Cardiac Gene Delivery of Adeno-Associated Virus Serotypes 1-9 reveals that AAV6 Mediates the Most Efficient Transduction in Mouse Heart
Carmela Zincarelli et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2010)
Update on non-viral delivery methods for cancer therapy: possibilities of a drug delivery system with anticancer activities beyond delivery as a new therapeutic tool
Yasufumi Kaneda
EXPERT OPINION ON DRUG DELIVERY (2010)
Near-perfect infectivity of wild-type AAV as benchmark for infectivity of recombinant AAV vectors
N. Zeltner et al.
GENE THERAPY (2010)
High-Efficiency Transduction of Fibroblasts and Mesenchymal Stem Cells by Tyrosine-Mutant AAV2 Vectors for Their Potential Use in Cellular Therapy
Mengxin Li et al.
HUMAN GENE THERAPY (2010)
Adeno-Associated Virus Serotype 6 Capsid Tyrosine-to-Phenylalanine Mutations Improve Gene Transfer to Skeletal Muscle
Chunping Qiao et al.
HUMAN GENE THERAPY (2010)
Enhanced Long-Term Transduction and Multilineage Engraftment of Human Hematopoietic Stem Cells Transduced with Tyrosine-Modified Recombinant Adeno-Associated Virus Serotype 2
M. Ariel Kauss et al.
HUMAN GENE THERAPY (2010)
Optimized Adeno-Associated Virus (AAV)-Protein Phosphatase-5 Helper Viruses for Efficient Liver Transduction by Single-Stranded AAV Vectors: Therapeutic Expression of Factor IX at Reduced Vector Doses
Giridhara R. Jayandharan et al.
HUMAN GENE THERAPY (2010)
Human Hepatocyte Growth Factor Receptor Is a Cellular Coreceptor for Adeno-Associated Virus Serotype
Chen Ling et al.
HUMAN GENE THERAPY (2010)
Mutagenesis of Adeno-Associated Virus Type 2 Capsid Protein VP1 Uncovers New Roles for Basic Amino Acids in Trafficking and Cell-Specific Transduction
Jarrod S. Johnson et al.
JOURNAL OF VIROLOGY (2010)
Structural Characterization of the Dual Glycan Binding Adeno-Associated Virus Serotype 6
Robert Ng et al.
JOURNAL OF VIROLOGY (2010)
High-efficiency Transduction and Correction of Murine Hemophilia B Using AAV2 Vectors Devoid of Multiple Surface-exposed Tyrosines
David M. Markusic et al.
MOLECULAR THERAPY (2010)
Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration
Francesca Simonelli et al.
MOLECULAR THERAPY (2010)
Epidermal growth factor receptor is a co-receptor for adeno-associated virus serotype 6
Melodie L. Weller et al.
NATURE MEDICINE (2010)
BAAV Transcytosis Requires an Interaction with β-1-4 Linked-Glucosamine and gp96
Giovanni Di Pasquale et al.
PLOS ONE (2010)
Magnetic nanoparticle-based isolation of endocytic vesicles reveals a role of the heat shock protein GRP75 in macromolecular delivery
Anders Wittrup et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A viral assembly factor promotes AAV2 capsid formation in the nucleolus
Florian Sonntag et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mechanisms of Endocytosis
Gary J. Doherty et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2009)
Adeno-associated virus type 5 exploits two different entry pathways in human embryo fibroblasts
Ursula Bantel-Schaal et al.
JOURNAL OF GENERAL VIROLOGY (2009)
Heparin binding induces conformational changes in Adeno-associated virus serotype 2
Hazel C. Levy et al.
JOURNAL OF STRUCTURAL BIOLOGY (2009)
Enhancement of Adeno-Associated Virus Infection by Mobilizing Capsids into and Out of the Nucleolus
Jarrod S. Johnson et al.
JOURNAL OF VIROLOGY (2009)
E4orf1 Limits the Oncolytic Potential of the E1B-55K Deletion Mutant Adenovirus
Michael A. Thomas et al.
JOURNAL OF VIROLOGY (2009)
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial
Albert M. Maguire et al.
LANCET (2009)
AAV3-mediated transfer and expression of the pyruvate dehydrogenase E1 alpha subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells
Lyudmyla G. Glushakova et al.
MOLECULAR GENETICS AND METABOLISM (2009)
High-efficiency Transduction of the Mouse Retina by Tyrosine-mutant AAV Serotype Vectors
Hilda Petrs-Silva et al.
MOLECULAR THERAPY (2009)
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2009)
Doxorubicin augments rAAV-2 transduction in rat neuronal cells
Ting Zhang et al.
NEUROCHEMISTRY INTERNATIONAL (2009)
Gene Therapy Fulfilling Its Promise.
Donald B. Kohn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Tracing the Retrograde Route in Protein Trafficking
Ludger Johannes et al.
CELL (2008)
Strategies for improving the transduction efficiency of single-stranded adeno-associated virus vectors in vitro and in vivo
G. R. Jayandharan et al.
GENE THERAPY (2008)
Novel AAV serotypes for improved ocular gene transfer
Corinna Lebherz et al.
JOURNAL OF GENE MEDICINE (2008)
Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection
Carmela Zincarelli et al.
MOLECULAR THERAPY (2008)
Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses
Li Zhong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression
Li Zhong et al.
VIROLOGY (2008)
Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration
B. Bostick et al.
GENE THERAPY (2007)
Novel adeno-associated virus serotypes efficiently transduce murine Photoreceptors
Mariacarmela Allocca et al.
JOURNAL OF VIROLOGY (2007)
A nucleolar targeting signal in PML-I addresses PML to nucleolar caps in stressed or senescent cells
Wilfried Condemine et al.
JOURNAL OF CELL SCIENCE (2007)
Pathways of clathrin-independent endocytosis
Satyajit Mayor et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Surface-exposed adeno-associated virus Vp1-NLS capsid fusion protein rescues infectivity of noninfectious wild-type Vp2/Vp3 and Vp3-only capsids but not that of fivefold pore mutant virions
Joshua C. Grieger et al.
JOURNAL OF VIROLOGY (2007)
A dual role of EGFR protein tyrosine kinase signaling in ubiquitination of AAV2 capsids and viral second-strand DNA synthesis
Li Zhong et al.
MOLECULAR THERAPY (2007)
A new crucial protein interaction element that targets the adenovirus E4-ORF1 oncoprotein to membrane vesicles
Sang-Hyuk Chung et al.
JOURNAL OF VIROLOGY (2007)
Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain
Jean-Marc Taymans et al.
HUMAN GENE THERAPY (2007)
A two-hybrid screen identifies cathepsins B and L as uncoating factors for adeno-associated virus 2 and 8
Bassel Akache et al.
MOLECULAR THERAPY (2007)
Adeno-associated virus interactions with B23/Nucleophosmin: Identification of sub-nucleolar virion regions
Joyce M. Bevington et al.
VIROLOGY (2007)
Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy
T. Vandendriessche et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Adeno-associated virus type 2 capsids with externalized VP1/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus
Florian Sonntag et al.
JOURNAL OF VIROLOGY (2006)
The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9
Bassel Akache et al.
JOURNAL OF VIROLOGY (2006)
Adeno-associated virus type 2 contains an integrin α5β1 binding domain essential for viral cell entry
Aravind Asokan et al.
JOURNAL OF VIROLOGY (2006)
α2,3 and α2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6
Zhijian Wu et al.
JOURNAL OF VIROLOGY (2006)
Rules for nuclear localization sequence recognition by karyopherinβ2
Brittany J. Lee et al.
CELL (2006)
Retrograde transport from endosomes to the trans-Golgi network
Juan S. Bonifacino et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Robust systemic transduction with AAV9 vectors in mice: Efficient global cardiac gene transfer superior to that of AAV8
Katsuya Inagaki et al.
MOLECULAR THERAPY (2006)
Separate basic region motifs within the adeno-associated virus capsid proteins are essential for infectivity and assembly
Joshua C. Grieger et al.
JOURNAL OF VIROLOGY (2006)
Gangliosides are essential for bovine adeno-associated virus entry
Michael Schmidt et al.
JOURNAL OF VIROLOGY (2006)
Retrograde transport pathways utilised by viruses and protein toxins
Robert A. Spooner et al.
VIROLOGY JOURNAL (2006)
rAAV2 traffics through both the late and the recycling endosomes in a dose-dependent fashion
W Ding et al.
MOLECULAR THERAPY (2006)
Attachment of adeno-associated virus type 3H to fibroblast growth factor receptor 1
SD Blackburn et al.
ARCHIVES OF VIROLOGY (2006)
AAV transcytosis through barrier epithelia and endothelium
G Di Pasquale et al.
MOLECULAR THERAPY (2006)
Parvovirus uncoating in vitro reveals a mechanism of DNA release without capsid disassembly and striking differences in encapsidated DNA stability
C Ros et al.
VIROLOGY (2006)
Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection
RM Richards et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Adeno-associated virus serotypes: Vector toolkit for human gene therapy
Zhijian Wu et al.
MOLECULAR THERAPY (2006)
Adeno-associated virus types 5 and 6 use distinct receptors for cell entry
MP Seiler et al.
HUMAN GENE THERAPY (2006)
Molecular characterization of adeno-associated viruses infecting children
CL Chen et al.
JOURNAL OF VIROLOGY (2005)
ERp29 triggers a conformational change in polyomavirus to stimulate membrane binding
B Magnuson et al.
MOLECULAR CELL (2005)
Localized gene expression following administration of adeno-associated viral vectors via pancreatic ducts
SA Loiler et al.
MOLECULAR THERAPY (2005)
A conformational change in the adeno-associated virus type 2 capsid leads to the exposure of hidden VP1N termini
S Kronenberg et al.
JOURNAL OF VIROLOGY (2005)
Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart
Z Wang et al.
NATURE BIOTECHNOLOGY (2005)
Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice
H Nakai et al.
JOURNAL OF VIROLOGY (2005)
The infectivity and lytic activity of minute virus of mice wild-type and derived vector particles are strikingly different
SI Lang et al.
JOURNAL OF VIROLOGY (2005)
Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection
Y Kashiwakura et al.
JOURNAL OF VIROLOGY (2005)
Successful gene transfer using adeno-associated virus vectors into the kidney: Comparison among adeno-associated virus serotype 1-5 vectors in vitro and in vivo
S Takeda et al.
NEPHRON EXPERIMENTAL NEPHROLOGY (2004)
Heat-shock treatment-mediated increase in transduction by recombinant adeno-associated virus 2 vectors is independent of the cellular heat-shock protein 90
L Zhong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Distinct classes of proteasome-modulating agents cooperatively augment recombinant adeno-associated virus type 2 and type 5-mediated transduction from the apical surfaces of human airway epithelia
ZY Yan et al.
JOURNAL OF VIROLOGY (2004)
Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors
CE Thomas et al.
JOURNAL OF VIROLOGY (2004)
Adenovirus endocytosis
O Meier et al.
JOURNAL OF GENE MEDICINE (2004)
Novel approaches to augment adeno-associated virus type-2 endocytosis and transduction
AD Sanlioglu et al.
VIRUS RESEARCH (2004)
Systemic delivery of genes to striated muscles using adeno-associated viral vectors
P Gregorevic et al.
NATURE MEDICINE (2004)
Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector
HB Gaspar et al.
LANCET (2004)
Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6
MJ Blankinship et al.
MOLECULAR THERAPY (2004)
Identification of a heparin-binding motif on adeno-associated virus type 2 capsids
A Kern et al.
JOURNAL OF VIROLOGY (2003)
Identification of PDGFR as a receptor for AAV-5 transduction
G Di Pasquale et al.
NATURE MEDICINE (2003)
Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain
C Wang et al.
GENE THERAPY (2003)
Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog, and nonhuman primate after subretinal delivery
M Weber et al.
MOLECULAR THERAPY (2003)
Immune responses to adeno-associated virus and its recombinant vectors
JY Sun et al.
GENE THERAPY (2003)
Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding
SR Opie et al.
JOURNAL OF VIROLOGY (2003)
AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B
CS Manno et al.
BLOOD (2003)
Adeno-associated virus type 2-mediated gene transfer: Role of cellular T-cell protein tyrosine phosphatase in transgene expression in established cell lines in vitro and Transgenic mice in vivo
KY Qing et al.
JOURNAL OF VIROLOGY (2003)
Mouse polyomavirus utilizes recycling endosomes for a traffic pathway independent of COPI vesicle transport
P Mannová et al.
JOURNAL OF VIROLOGY (2003)
Adenovirus-facilitated nuclear translocation of adeno-associated virus type 2
W Xiao et al.
JOURNAL OF VIROLOGY (2002)
Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells
K Pajusola et al.
JOURNAL OF VIROLOGY (2002)
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
GP Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity
A Girod et al.
JOURNAL OF GENERAL VIROLOGY (2002)
Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity
JE Rabinowitz et al.
JOURNAL OF VIROLOGY (2002)
Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors
ZY Yan et al.
JOURNAL OF VIROLOGY (2002)
Endocytosis of adeno-associated virus type 5 leads to accumulation of virus particles in the Golgi compartment
U Bantel-Schaal et al.
JOURNAL OF VIROLOGY (2002)
Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity
N Kaludov et al.
JOURNAL OF VIROLOGY (2001)
Enhancement of muscle gene delivery with pseudotyped adeno-associated virus type 5 correlates with myoblast differentiation
DS Duan et al.
JOURNAL OF VIROLOGY (2001)
Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors
CL Halbert et al.
JOURNAL OF VIROLOGY (2001)
Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer
RW Walters et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Infection of endothelium with E1-E4+, but not E1-E4-, adenovirns gene transfer vectors enhances leukocyte adhesion and migration by modulation of ICAM-1, VCAM-1, CD34, and chemokine expression
S Rafii et al.
CIRCULATION RESEARCH (2001)
Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER
L Pelkmans et al.
NATURE CELL BIOLOGY (2001)
Adeno-associated virus type 2-mediated gene transfer: Altered endocytic processing enhances transduction efficiency in murine fibroblasts
J Hansen et al.
JOURNAL OF VIROLOGY (2001)
Intracellular trafficking of adeno-associated virus vectors: Routing to the late endosomal compartment and proteasome degradation
AM Douar et al.
JOURNAL OF VIROLOGY (2001)
Proteins associated with the promyelocytic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation
K Mattsson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors
HJ Chao et al.
MOLECULAR THERAPY (2000)
Synaptojanin 2, a novel Rac1 effector that regulates clathrin-mediated endocytosis
N Malecz et al.
CURRENT BIOLOGY (2000)
Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by Rac1 and phosphatidylinositol-3 kinase activation
S Sanlioglu et al.
JOURNAL OF VIROLOGY (2000)
Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus
DS Duan et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: Cell cycling does not influence hepatocyte transduction
CH Miao et al.
JOURNAL OF VIROLOGY (2000)
Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors
JS Bartlett et al.
JOURNAL OF VIROLOGY (2000)
Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
M Cavazzana-Calvo et al.
SCIENCE (2000)
Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous system
BL Davidson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts
J Hansen et al.
JOURNAL OF VIROLOGY (2000)
Regulation of adenovirus membrane penetration by the cytoplasmic tail of integrin beta 5
K Wang et al.
JOURNAL OF VIROLOGY (2000)
Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism
P Wu et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
